(Q44935457)

7 December 2017

Early adequate mycophenolic acid exposure is associated with less rejection in kidney transplantation (English)

1 reference

7 December 2017

Bryce A Kiberd

1

1 reference

7 December 2017

Joseph Lawen

2

1 reference

7 December 2017

Albert D Fraser

3

1 reference

7 December 2017

Tammy Keough-Ryan

4

1 reference

7 December 2017

Philip Belitsky

5

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

American Journal of Transplantation

7 December 2017

5

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

7 December 2017

4

1 reference

7 December 2017

7

1 reference

7 December 2017

1079-1083

1 reference

Neoral use in the renal transplant recipient

7 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00455.X

Adequate early cyclosporin exposure is critical to prevent renal allograft rejection: patients monitored by absorption profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00455.X

A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00455.X

Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00455.X

Mycophenolate mofetil for solid organ transplantation: does the evidence support the need for clinical pharmacokinetic monitoring?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00455.X

Determination of mycophenolate area under the curve by limited sampling strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00455.X

Basiliximab widens the therapeutic window for AUC-monitored neoral therapy early after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00455.X

Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00455.X

WOFIE synergizes with calcineurin-inhibitor treatment and early steroid withdrawal in kidney transplantation1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00455.X

Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00455.X

Anti-CD25 monoclonal antibody therapy affects the death signals of graft-infiltrating cells after clinical heart transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00455.X

10.1111/J.1600-6143.2004.00455.X

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference